ARTEMIDE-Gastric01 trial: what clinicians have said so far
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
- NCT06764875 ↗
- Recruiting
- AstraZeneca
- Standard size, estimated: 151–300 verified statements once built
We haven't built an HCP commentary report on ARTEMIDE-Gastric01 (rilvegostomig plus trastuzumab deruxtecan in first-line HER2-positive gastric or gastroesophageal junction cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on ARTEMIDE-Gastric01 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 5 YouTube videos, typically up to 22 once built | |
| 4 podcast episodes, typically up to 18 once built | |
| 2 posts on X, typically up to 9 once built |
The trial
ClinicalTrials.gov- Official title
- A Randomized, Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan Versus Trastuzumab, Chemotherapy, and Pembrolizumab for the First Line Treatment of HER2-positive Gastric Cancer (ARTEMIDE-Gastric01)
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- HER2-positive Gastric Cancer; Gastroesophageal Junction Adenocarcinoma
- Interventions
- Rilvegostomig; Trastuzumab deruxtecan; Trastuzumab; Pembrolizumab; 5-fluorouracil; Capecitabine; Cisplatin; Oxaliplatin
- Arms
- Arm A · Experimental
- Arm B · Active comparator
- Arm C · Active comparator
- Enrollment
- 840 (estimated)
- Primary outcomes
- Progression free survival (PFS)
- Overall Survival (OS)
- Sponsor
- AstraZeneca
- Start
- Mar 1, 2025
- Primary completion
- Apr 27, 2029 (estimated)
- Results posted
- No
- Registry record
- NCT06764875 · updated Oct 16, 2026